Protein Synthesis Inhibitors

All categories
DBCAT000501Pharmacologic class

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. A DrugBank category of 41 drugs. 24 of them are approved.

Also known as
Antagonists, Protein Synthesis · Protein Synthesis Antagonists · Inhibitors, Protein Synthesis
Drugs

and 16 more with a free account

What you can answer from here — as of August 24, 2016

41DrugsEach linked to its full drug card
Sign in
70Drug targetsEvery drug–target pair in the class, with bond type
Sign in
8,078Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
27Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Protein Synthesis Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In